Literature DB >> 3154332

Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis.

J F Renaud1.   

Abstract

The effects of trimetazidine were studied on plasma membrane structures of cardiac cells which control excitability, as well as on cardiac cells that were cultured in normal physiologic conditions and after intracellular acidification. When cardiac cells were kept in normal physiologic conditions, trimetazidine at concentrations ranging from 10(-8) to 3.10(-4) M interacted neither directly nor indirectly with the major ionic transporter systems of cardiac cells, such as ionic channels (Na+, K+), ATPase, Na+/H+, and Na+/Ca2+ exchange systems. Under acid-load conditions trimetazide acts in a dose- and time-dependent manner, in limiting the accumulation of Na+ and Ca2+ inside cardiac cells and depressing intracellular cell acidosis. It is proposed that trimetazidine plays a key role in limiting the intracellular accumulation of protons that is responsible for cell acidosis during ischemia. Trimetazidine, in protecting cardiac cells against accumulation of protons, limits accumulation of Na+ and Ca2+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154332     DOI: 10.1007/bf02125756

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

Review 1.  Kinetic properties of the plasma membrane Na+-H+ exchanger.

Authors:  P S Aronson
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 2.  The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH.

Authors:  M Lazdunski; C Frelin; P Vigne
Journal:  J Mol Cell Cardiol       Date:  1985-11       Impact factor: 5.000

3.  Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia.

Authors:  L H Opie
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

4.  An investigation of the ionic mechanism of intracellular pH regulation in mouse soleus muscle fibres.

Authors:  C C Aickin; R C Thomas
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

Review 5.  The action of cardiotoxins on cardiac plasma membranes.

Authors:  M Lazdunski; J F Renaud
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

Review 6.  Intracellular pH.

Authors:  A Roos; W F Boron
Journal:  Physiol Rev       Date:  1981-04       Impact factor: 37.312

7.  The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium.

Authors:  P D Bourdillon; P A Poole-Wilson
Journal:  Circ Res       Date:  1982-03       Impact factor: 17.367

8.  Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies.

Authors:  K A Reimer; R B Jennings; A H Tatum
Journal:  Am J Cardiol       Date:  1983-07-20       Impact factor: 2.778

9.  Effects of trimetazidine on action potentials and membrane currents of guinea-pig ventricular myocytes.

Authors:  T Kiyosue; S Nakamura; M Arita
Journal:  J Mol Cell Cardiol       Date:  1986-12       Impact factor: 5.000

10.  [Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart].

Authors:  N Lavanchy; J Martin; A Rossi
Journal:  Presse Med       Date:  1986-10-16       Impact factor: 1.228

View more
  22 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

2.  Antiischemic effects of trimetazidine: 31P-NMR spectroscopy study in the isolated rat heart.

Authors:  A Rossi; N Lavanchy; J Martin
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Protective effects of trimetazidine on bone marrow mesenchymal stem cells viability in an ex vivo model of hypoxia and in vivo model of locally myocardial ischemia.

Authors:  Hongxin Xu; Gangyan Zhu; Yihao Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

4.  Acute oral trimetazidine administration increases resting technetium 99m sestamibi uptake in hibernating myocardium.

Authors:  M Ciavolella; C Greco; R Tavolaro; G Tanzilli; F Scopinaro; P P Campa
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 5.  Myocardial ischemia--metabolic pathways and implications of increased glycolysis.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 6.  Pharmacology of acute effort angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

7.  Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.

Authors:  P Di Napoli; A A Taccardi; A Barsotti
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

8.  Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

Authors:  J M Detry; P Sellier; S Pennaforte; D Cokkinos; H Dargie; P Mathes
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

9.  Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats.

Authors:  Arzu Didem Yalcin; Atil Bisgin; Riza Hakan Erbay; Oguzhan Oguz; Suleyman Demir; Mustafa Yilmaz; Saadet Gumuslu
Journal:  Int J Burns Trauma       Date:  2012-09-15

10.  Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte.

Authors:  D Lagadic-Gossmann; K Le Prigent; D Feuvray
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.